The global demand for Antimicrobial Peptides Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020- 2026.
Antimicrobial peptides or AMPs are also referred to as ‘host defense peptides. Antimicrobial peptides are defined as polypeptide antimicrobial substances, which participate in the innate immune system and can protect the host from invasive microbial infections. Additionally, these have the ability to kill microbial pathogens directly. It has application across pharma and healthcare, agriculture industry and biological engineering.
Market Dynamics
The rapidly rising investment in research and development of antibiotics by many significant players is driving the market growth. However, multiple cases of antibiotic resistance have caused a concern in the healthcare industry, which is a major threat and may affect adversely the market growth. Whereas, properties associated with antimicrobial peptides such as high specificity, decreased drug interaction, low toxicity, biological diversity, and the direct attacking property is likely to create potential demand over the forecast period.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of antimicrobial peptides.
Market Segmentation
The entire antimicrobial peptides market has been sub-categorized into product type and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Product Type
- Plant Antimicrobial Peptides
- Bacterial Antimicrobial Peptides
- Animal Antimicrobial Peptides
- Insect Antimicrobial Peptides
By Application
- Pharma and Healthcare
- Agriculture Industry
- Biological Engineering
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for antimicrobial peptides market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Europe Antimicrobial Peptides Market By Revenue (USD MN)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the antimicrobial peptides market include AnaSpec, AMP Biotech, Chinese Peptide, Novozymes, Phoenix Biotech and Shanghai Abbiochem Company. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
METHODOLOGY:
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.